One-Year Mortality in Patients Undergoing an Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy Pulse Generator Replacement: Identifying Patients at Risk
Implantable cardioverter defibrillators (ICDs) significantly contribute to the prevention of sudden cardiac death in selected patients. However, it is essential to identify those who are likely to not have benefit from an ICD and to defer a pulse generator exchange. Easily implementable guidelines f...
Main Authors: | Michelle Feijen, Anastasia D. Egorova, Teresa Kuijken, Marianne Bootsma, Martin J. Schalij, Lieselot van Erven |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/17/5654 |
Similar Items
-
Effects of COVID‐19 lockdown on arrhythmias in patients with implantable cardioverter‐defibrillators in southern Italy
by: Valentino Ducceschi, et al.
Published: (2022-06-01) -
Implantable Cardioverter Defibrillator Multisensor Monitoring during Home Confinement Caused by the COVID-19 Pandemic
by: Matteo Ziacchi, et al.
Published: (2022-01-01) -
Performance of a multisensor implantable defibrillator algorithm for heart failure monitoring related to co‐morbidities
by: Vincenzo Ezio Santobuono, et al.
Published: (2023-08-01) -
Arrhythmic and mortality outcomes in patients with dilated cardiomyopathy receiving cardiac resynchronization therapy without defibrillator
by: Mohammed Samy, et al.
Published: (2023-11-01) -
An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy
by: Fuwei Liu, et al.
Published: (2023-07-01)